Literature DB >> 12394995

One-shot percutaneous electrical nerve stimulation vs. transcutaneous electrical nerve stimulation for low back pain: comparison of therapeutic effects.

Ru-Lan Hsieh1, Wen-Chung Lee.   

Abstract

OBJECTIVE: To investigate the therapeutic effects of one shot of low-frequency percutaneous electrical nerve stimulation one shot of transcutaneous electrical nerve stimulation in patients with low back pain.
DESIGN: In total, 133 low back pain patients were recruited for this randomized, control study. Group 1 patients received medication only. Group 2 patients received medication plus one shot of percutaneous electrical nerve stimulation. Group 3 patients received medication plus one shot of transcutaneous electrical nerve stimulation. Therapeutic effects were measured using a visual analog scale, body surface score, pain pressure threshold, and the Quebec Back Pain Disability Scale.
RESULTS: Immediately after one-shot treatment, the visual analog scale improved 1.53 units and the body surface score improved 3.06 units in the percutaneous electrical nerve stimulation group. In the transcutaneous electrical nerve stimulation group, the visual analog scale improved 1.50 units and the body surface score improved 3.98 units. The improvements did not differ between the two groups. There were no differences in improvement at 3 days or 1 wk after the treatment among the three groups.
CONCLUSIONS: Simple one-shot treatment with percutaneous electrical nerve stimulation or transcutaneous electrical nerve stimulation provided immediate pain relief for low back pain patients. One-shot transcutaneous electrical nerve stimulation treatment is recommended due to the rarity of side effects and its convenient application.

Entities:  

Mesh:

Year:  2002        PMID: 12394995     DOI: 10.1097/00002060-200211000-00006

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  7 in total

Review 1.  Transcutaneous electrical nerve stimulation (TENS) versus placebo for chronic low-back pain.

Authors:  Amole Khadilkar; Daniel Oluwafemi Odebiyi; Lucie Brosseau; George A Wells
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

Review 2.  Does TENS Reduce the Intensity of Acute and Chronic Pain? A Comprehensive Appraisal of the Characteristics and Outcomes of 169 Reviews and 49 Meta-Analyses.

Authors:  Carole A Paley; Priscilla G Wittkopf; Gareth Jones; Mark I Johnson
Journal:  Medicina (Kaunas)       Date:  2021-10-04       Impact factor: 2.430

Review 3.  Characterising the Features of 381 Clinical Studies Evaluating Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Relief: A Secondary Analysis of the Meta-TENS Study to Improve Future Research.

Authors:  Mark I Johnson; Carole A Paley; Priscilla G Wittkopf; Matthew R Mulvey; Gareth Jones
Journal:  Medicina (Kaunas)       Date:  2022-06-14       Impact factor: 2.948

4.  Effectiveness of preemptive analgesia using a frequency rhythmic electrical modulation system in patients having instrumented fusion for lumbar stenosis.

Authors:  Serhat Aydoğan; Uygur Er; Onur Ozlü
Journal:  Asian Spine J       Date:  2014-04-08

Review 5.  Effects of Ultrasound-Guided Nerve Stimulation Targeting Peripheral Nerve Tissue on Pain and Function: A Scoping Review.

Authors:  Agustín García-Collado; Juan A Valera-Calero; César Fernández-de-Las-Peñas; José L Arias-Buría
Journal:  J Clin Med       Date:  2022-06-28       Impact factor: 4.964

6.  Local and systemic cardiovascular effects from monochromatic infrared therapy in patients with knee osteoarthritis: a double-blind, randomized, placebo-controlled study.

Authors:  Ru-Lan Hsieh; Wei-Cheng Liao; Wen-Chung Lee
Journal:  Evid Based Complement Alternat Med       Date:  2012-06-27       Impact factor: 2.629

7.  Literature Review and Meta-Analysis of Transcutaneous Electrical Nerve Stimulation in Treating Chronic Back Pain.

Authors:  Lien-Chen Wu; Pei-Wei Weng; Chia-Hsien Chen; Yi-You Huang; Yang-Hwei Tsuang; Chang-Jung Chiang
Journal:  Reg Anesth Pain Med       Date:  2018-05       Impact factor: 6.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.